Alle verbonden artikelen

Cutaneous lesions of Anderson-Fabry disease examined with a novel technique: Line-field confocal optical coherence tomography.

Auteurs : Tognetti L, Cinotti E, Coriolani G, Suppa M, Perrot JL, Vascotto M, Grosso S, Rubegni P
Jaar : 2022
Journal : J Eur Acad Dermatol Venereol
Volume : 36
Pagina's : e371-e373

Cancer cells resist antibody-mediated destruction by neutrophils through activation of the exocyst complex.

Auteurs : van Rees DJ, Bouti P, Klein B, Verkuijlen PJH, van Houdt M, Schornagel K, Tool ATJ, Venet D, Sotiriou C, El-Abed S, Izquierdo M, Guillaume S, Saura C, Di Cosimo S, Huober J, Roylance R, Kim SB, Kuijpers TW, van Bruggen R, K van den Berg T, Matlung HL
Jaar : 2022
Journal : J Immunother Cancer
Volume : 10

Unresectable and chemoresistant conjunctival squamous cell carcinoma on xeroderma pigmentosum treated by salvage radiation therapy: A case report and a review of the literature.

Auteurs : Maimouna M, Sofian B, Latifatou G, Joséphine Frédérique Mendouga E, Papa Macoumba G, Mamadou Moustapha D, Dirk VG
Jaar : 2022
Journal : Clin Case Rep
Volume : 10
Pagina's : e6360

Immature squamous metaplasia of esophageal glands associated with squamous cell carcinoma.

Auteurs : Verset L, Huberty V, Bourgeois V, Lemmers A, Demetter P
Jaar : 2022
Journal : Acta Gastroenterol Belg
Volume : 85
Pagina's : 396-399

Beta-2 Adrenergic Receptor Gene Expression in HER2-Positive Early-Stage Breast Cancer Patients: A Post-hoc Analysis of the NCCTG-N9831 (Alliance) Trial.

Auteurs : Caparica R, Ma Y, de Angelis C, Richard F, Desmedt C, Awada A, Piccart M, Perez EA, Moreno-Aspitia A, Badve S, Thompson EA, de Azambuja E
Jaar : 2022
Journal : Clin Breast Cancer
Volume : 22
Pagina's : 308-318

A nomogram to predict the recurrence-free survival and analyze the utility of chemotherapy in stage IB non-small cell lung cancer.

Auteurs : Zhang Z, Xie S, Cai W, Hong ZN, Yang C, Lin Y, Zhu J, Lin Z, Christoph DC, Bohnenberger H, Kepka L, Brueckl WM, Van Houtte P, Kang M, Lin J
Jaar : 2022
Journal : Transl Lung Cancer Res
Volume : 11
Pagina's : 75-86

External validation of FRISBEE 5-year fracture prediction models: a registry-based cohort study.

Auteurs : Agarwal A, Baleanu F, Moreau M, Charles A, Iconaru L, Surquin M, Benoit F, Paesmans M, Karmali R, Bergmann P, Body JJ, Leslie WD
Jaar : 2022
Journal : Arch Osteoporos
Volume : 18
Pagina's : 13

Bioscreening and pre-clinical evaluation of the impact of bioactive molecules from Ptychotis verticillata on the multilineage potential of mesenchymal stromal cells towards immune- and inflammation-mediated diseases.

Auteurs : Bouhtit F, Najar M, Rahmani S, Melki R, Najimi M, Sadki K, Boukhatem N, Twizere JC, Meuleman N, Lewalle P, Lagneaux L, Merimi M
Jaar : 2022
Journal : Inflamm Res
Volume : 71
Pagina's : 887-898

EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds.

Auteurs : Weber M, Lam M, Chiesa C, Konijnenberg M, Cremonesi M, Flamen P, Gnesin S, Bodei L, Kracmerova T, Luster M, Garin E, Herrmann K
Jaar : 2022
Journal : Eur J Nucl Med Mol Imaging
Volume : 49
Pagina's : 1682-1699

Erratum to Gene expression signatures for tailoring adjuvant chemotherapy of luminal breast cancer: stronger evidence, greater trust": [Annals of Oncology 32 (2021) 1077-1082]."

Auteurs : Piccart MJ, Kalinsky K, Gray R, Barlow WE, Poncet C, Cardoso F, Winer E, Sparano J
Jaar : 2022
Journal : Ann Oncol
Volume : 33
Pagina's : 668

Obinutuzumab plus lenalidomide in advanced, previously untreated follicular lymphoma in need of systemic therapy: a LYSA study.

Auteurs : Bachy E, Houot R, Feugier P, Bouabdallah K, Bouabdallah R, Virelizier EN, Maerevoet M, Fruchart C, Snauwaert S, Le Gouill S, Marolleau JP, Molina L, Moluçon-Chabrot C, Thieblemont C, Tilly H, Bijou F, Haioun C, Van Den Neste E, Fabiani B, Meignan M, Cartron G, Salles G, Casasnovas O, Morschhauser F
Jaar : 2022
Journal : Blood
Volume : 139
Pagina's : 2338-2346

Functional status in older patients with cancer and a frailty risk profile: A multicenter observational study.

Auteurs : Meert G, Kenis C, Milisen K, Debruyne PR, De Groof I, Focan C, Cornélis F, Verschaeve V, Bachmann C, Bron D, Den Bulck HV, Schrijvers D, Langenaeken C, Specenier P, Jerusalem G, Praet JP, Lobelle JP, Flamaing J, Wildiers H, Decoster L
Jaar : 2022
Journal : J Geriatr Oncol
Volume : 13
Pagina's : 1162-1171

First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors.

Auteurs : Kim TW, Burris HA, de Miguel Luken MJ, Pishvaian MJ, Bang YJ, Gordon M, Awada A, Camidge DR, Hodi FS, McArthur GA, Miller WH, Cervantes A, Chow LQ, Lesokhin AM, Rutten A, Sznol M, Rishipathak D, Chen SC, Stefanich E, Pourmohamad T, Anderson M, Kim J, Huseni M, Rhee I, Siu LL
Jaar : 2022
Journal : Clin Cancer Res
Volume : 28
Pagina's : 3452-3463

Cost-analysis of robot-assisted radical cystectomy in Europe: A cross-country comparison.

Auteurs : Mjaess G, Diamand R, Aoun F, Assenmacher G, Assenmacher C, Verhoest G, Holz S, Naudin M, Ploussard G, Mari A, Tay A, Issa R, Roumiguié M, Bajeot AS, Umari P, Sridhar A, Kelly J, Hendricksen K, Einerhand S, Mertens LS, Sanchez-Salas R, Gallardo AC, Quackels T, Peltier A, Pradere B, Moschini M, Roumeguère T, Albisinni S
Jaar : 2022
Journal : Eur J Surg Oncol

Grade group 1 prostate cancer on biopsy: are we still missing aggressive disease in the era of image-directed therapy?

Auteurs : Baboudjian M, Roumiguié M, Peltier A, Oderda M, Barret E, Fromont G, Dariane C, Fiard G, Charvet AL, Gondran-Tellier B, Durand-Labrunie C, Campello PV, Roumeguère T, Diamand R, Diana P, Touzani A, Beauval JB, Daniel L, Rouprêt M, Ruffion A, Ploussard G
Jaar : 2022
Journal : World J Urol
Volume : 40
Pagina's : 2423-2429

Endoscopic Bariatric and Metabolic Therapies on Nonalcoholic Fatty Liver Disease: Enough Data to be Considered Effective?

Auteurs : Hadefi A, Gkolfakis P, Devière J
Jaar : 2022
Journal : Clin Gastroenterol Hepatol
Volume : 20
Pagina's : 1186-1187

The oxygen sensor prolyl hydroxylase domain 2 regulates the in vivo suppressive capacity of regulatory T cells.

Auteurs : Ajouaou Y, Azouz A, Taquin A, Denanglaire S, Hussein H, Krayem M, Andris F, Moser M, Goriely S, Leo O
Jaar : 2022
Journal : Elife
Volume : 11

HER2-Low Breast Cancer: Where Are We?

Auteurs : Molinelli C, Jacobs F, Marchiò C, Pitto F, Cosso M, Spinaci S, de Azambuja E, Schettini F, Agostinetto E, Lambertini M
Jaar : 2022
Journal : Breast Care (Basel)
Volume : 17
Pagina's : 533-545

ROSALINE: a phase II, neoadjuvant study targeting ROS1 in combination with endocrine therapy in invasive lobular carcinoma of the breast.

Auteurs : Agostinetto E, Nader-Marta G, Paesmans M, Ameye L, Veys I, Buisseret L, Neven P, Taylor D, Fontaine C, Duhoux FP, Canon JL, Denys H, Coussy F, Chakiba C, Ribeiro JM, Piccart M, Desmedt C, Ignatiadis M, Aftimos P
Jaar : 2022
Journal : Future Oncol
Volume : 18
Pagina's : 2383-2392

Progress and pitfalls in the use of immunotherapy for patients with triple negative breast cancer.

Auteurs : Agostinetto E, Losurdo A, Nader-Marta G, Santoro A, Punie K, Barroso R, Popovic L, Solinas C, Kok M, de Azambuja E, Lambertini M
Jaar : 2022
Journal : Expert Opin Investig Drugs
Volume : 31
Pagina's : 567-591